Administering immunotherapy in the morning seems to matter. Why?
a year ago
- #immunotherapy
- #cancer-treatment
- #circadian-rhythm
- Immunotherapy administered in the morning shows significant improvements in cancer control and patient survival.
- Randomized clinical trials and retrospective studies support the benefits of morning immunotherapy, termed 'immunochronotherapy'.
- Circadian rhythms influence immune system activity, with higher lymphocyte concentrations in the morning.
- Morning administration may enhance T-cell activation and dendritic cell function, improving immunotherapy efficacy.
- Despite long half-lives of immunotherapy drugs, initial dosing time appears crucial for long-term outcomes.
- Mechanisms behind timing effects remain unclear, but may involve multiple small biological advantages in the morning.
- Historical parallels exist with disproven chronotherapy claims in hypertension treatment, warranting caution.
- Ongoing and future clinical trials aim to validate and explore chronoimmunotherapy further.